Datasets:
SKT27182
/
NER_processed_data

Dataset card Data Studio Files
xet
Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT02687464
39:47:cancer
presentation with an appendix mass or phlegmon (on physical examination and/or imaging)
1
[ "presentation", "with", "an", "appendix", "mass", "or", "phlegmon", "(", "on", "physical", "examination", "and/or", "imaging", ")" ]
[ 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0 ]
NCT03002389
12:43:chronic_disease
History of alpha 1 anti-trypsin deficiency
1
[ "History", "of", "alpha", "1", "anti-trypsin", "deficiency" ]
[ 0, 0, 2, 2, 2, 2 ]
NCT02015390
35:50:cancer
Disseminated and/or nonresectable malignant tumor involving bone
1
[ "Disseminated", "and/or", "nonresectable", "malignant", "tumor", "involving", "bone" ]
[ 0, 0, 0, 3, 3, 0, 0 ]
NCT02131597
,,,,,157:170:treatment
Women who are able to become pregnant and men who can father a child must use birth control while on study and for at least 8 weeks after your last dose of study drug(s)
1
[ "Women", "who", "are", "able", "to", "become", "pregnant", "and", "men", "who", "can", "father", "a", "child", "must", "use", "birth", "control", "while", "on", "study", "and", "for", "at", "least", "8", "weeks", "after", "your", "last", "dose", "of", "study", "drug", "(", "s", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02180412
,149:158:chronic_disease
Acute symptoms (7 days duration or less to time of enrollment) such as abdominal, back and/or limb pain, diagnosed by the investigator as caused by porphyria after initial evaluation has excluded other causes
1
[ "Acute", "symptoms", "(", "7", "days", "duration", "or", "less", "to", "time", "of", "enrollment", ")", "such", "as", "abdominal", ",", "back", "and/or", "limb", "pain", ",", "diagnosed", "by", "the", "investigator", "as", "caused", "by", "porphyria", "after", "initial", "evaluation", "has", "excluded", "other", "causes" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT03090607
,,41:52:treatment
GERD-HRQL score ≥15 after discontinuing PPI therapy
1
[ "GERD-HRQL", "score", "≥15", "after", "discontinuing", "PPI", "therapy" ]
[ 0, 0, 0, 0, 0, 1, 1 ]
NCT02200445
,,,104:113:treatment,
Men and women of reproductive potential must agree to use an acceptable method of birth control during treatment and for six months after completion of treatment
1
[ "Men", "and", "women", "of", "reproductive", "potential", "must", "agree", "to", "use", "an", "acceptable", "method", "of", "birth", "control", "during", "treatment", "and", "for", "six", "months", "after", "completion", "of", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02236013
76:85:treatment
Subject agrees not to participate in another interventional study while on treatment
1
[ "Subject", "agrees", "not", "to", "participate", "in", "another", "interventional", "study", "while", "on", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT01174121
42:72:treatment
Grade 3 or 4 major organ irAEs following treatment with anti-PD-1/PD-L1
1
[ "Grade", "3", "or", "4", "major", "organ", "irAEs", "following", "treatment", "with", "anti-PD-1/PD-L1" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT02099591
49:61:treatment
Patients currently receiving the first cycle of chemotherapy
1
[ "Patients", "currently", "receiving", "the", "first", "cycle", "of", "chemotherapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02003222
18:30:treatment
RANDOMIZATION TO BLINATUMOMAB OR NO BLINATUMOMAB-STEP 3
1
[ "RANDOMIZATION", "TO", "BLINATUMOMAB", "OR", "NO", "BLINATUMOMAB-STEP", "3" ]
[ 0, 0, 1, 0, 0, 0, 0 ]
NCT01532687
1:23:chronic_disease
Malabsorption syndrome
1
[ "Malabsorption", "syndrome" ]
[ 2, 2 ]
NCT02091999
1:13:treatment
chemotherapy
1
[ "chemotherapy" ]
[ 1 ]
NCT02315612
47:51:treatment,86:93:chronic_disease,150:177:treatment
(For children who are unable to cooperate for PFTs, the criterion is: No evidence of dyspnea at rest, no exercise intolerance and no requirement for supplemental oxygen therapy. )
1
[ "(", "For", "children", "who", "are", "unable", "to", "cooperate", "for", "PFTs", ",", "the", "criterion", "is", ":", "No", "evidence", "of", "dyspnea", "at", "rest", ",", "no", "exercise", "intolerance", "and", "no", "requirement", "for", "supplemental", "oxygen", "therapy", ".", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0 ]
NCT02503722
15:24:treatment,28:34:treatment,64:89:treatment,
substrates of CYP 3A4/5 or CYP1A2 that are sensitive or have a narrow therapeutic window at least three weeks prior to study registration
1
[ "substrates", "of", "CYP", "3A4/5", "or", "CYP1A2", "that", "are", "sensitive", "or", "have", "a", "narrow", "therapeutic", "window", "at", "least", "three", "weeks", "prior", "to", "study", "registration" ]
[ 0, 0, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02478684
11:31:chronic_disease
Any major congenital anomalies
1
[ "Any", "major", "congenital", "anomalies" ]
[ 0, 0, 2, 2 ]
NCT02565901
1:20:chronic_disease,31:49:chronic_disease,68:75:treatment
Atrial fibrillation, or other cardiac arrhythmia requiring medical therapy
1
[ "Atrial", "fibrillation", ",", "or", "other", "cardiac", "arrhythmia", "requiring", "medical", "therapy" ]
[ 2, 2, 0, 0, 0, 2, 2, 0, 0, 1 ]
NCT01676259
10:20:chronic_disease
unstable arrhythmia
1
[ "unstable", "arrhythmia" ]
[ 0, 2 ]
NCT01648023
15:37:chronic_disease,,
Patients with liver-dominant disease defined as ≥80% tumor burden confined to the liver
1
[ "Patients", "with", "liver-dominant", "disease", "defined", "as", "≥80", "%", "tumor", "burden", "confined", "to", "the", "liver" ]
[ 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02407028
25:58:treatment,,112:122:treatment,123:134:treatment,138:162:treatment
Ability to initiate the first hyperbaric oxygen treatment within 14 hours of admission in patients requiring a craniotomy/craniectomy or major surgical procedure
1
[ "Ability", "to", "initiate", "the", "first", "hyperbaric", "oxygen", "treatment", "within", "14", "hours", "of", "admission", "in", "patients", "requiring", "a", "craniotomy/craniectomy", "or", "major", "surgical", "procedure" ]
[ 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 1 ]
NCT01543490
40:49:treatment
provide documentation for having had a vasectomy (with documented infertility)
1
[ "provide", "documentation", "for", "having", "had", "a", "vasectomy", "(", "with", "documented", "infertility", ")" ]
[ 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0 ]
NCT02592707
20:29:treatment,33:43:treatment,72:79:cancer,84:92:cancer,124:150:treatment
In countries where sunitinib or everolimus are marketed, patients with GEP NET and lung NET will be progressive under this prior anti-tumor treatment for the respective indication
1
[ "In", "countries", "where", "sunitinib", "or", "everolimus", "are", "marketed", ",", "patients", "with", "GEP", "NET", "and", "lung", "NET", "will", "be", "progressive", "under", "this", "prior", "anti-tumor", "treatment", "for", "the", "respective", "indication" ]
[ 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 3, 3, 0, 3, 3, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0 ]
NCT02531880
19:22:chronic_disease
Positive test for HIV
1
[ "Positive", "test", "for", "HIV" ]
[ 0, 0, 0, 2 ]
NCT02037048
,40:52:treatment
for 90 days following the last dose of chemotherapy
1
[ "for", "90", "days", "following", "the", "last", "dose", "of", "chemotherapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02953509
1:26:treatment
Prior treatment with CD47
1
[ "Prior", "treatment", "with", "CD47" ]
[ 1, 1, 1, 1 ]
NCT02061761
1:19:chronic_disease
Autoimmune disease
1
[ "Autoimmune", "disease" ]
[ 2, 2 ]
NCT02347995
1:9:chronic_disease
dementia by clinical evaluation
1
[ "dementia", "by", "clinical", "evaluation" ]
[ 2, 0, 0, 0 ]
NCT02264678
37:48:allergy_name
Contra-indicated for treatment with carboplatin
1
[ "Contra-indicated", "for", "treatment", "with", "carboplatin" ]
[ 0, 0, 0, 0, 4 ]
NCT02639065
49:61:chronic_disease
Known history of previous clinical diagnosis of tuberculosis
1
[ "Known", "history", "of", "previous", "clinical", "diagnosis", "of", "tuberculosis" ]
[ 0, 0, 0, 0, 0, 0, 0, 2 ]
NCT02167958
1:13:treatment
Chemotherapy-sensitive (complete or partial response
1
[ "Chemotherapy-sensitive", "(", "complete", "or", "partial", "response" ]
[ 1, 0, 0, 0, 0, 0 ]
NCT02311361
,,,,,,255:264:treatment
Enrolled patients must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry, the duration of study participation and 180 days (female patients) or 90 days (male patients) after the end of the treatment
1
[ "Enrolled", "patients", "must", "agree", "to", "use", "adequate", "contraception", "(", "hormonal", "or", "barrier", "method", "of", "birth", "control", ";", "abstinence", ")", "prior", "to", "study", "entry", ",", "the", "duration", "of", "study", "participation", "and", "180", "days", "(", "female", "patients", ")", "or", "90", "days", "(", "male", "patients", ")", "after", "the", "end", "of", "the", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02240498
10:46:chronic_disease
Severely compromised cardiopulmonary function
1
[ "Severely", "compromised", "cardiopulmonary", "function" ]
[ 0, 2, 2, 2 ]
NCT02498613
73:83:cancer,112:146:cancer,152:187:cancer,,,,284:310:treatment,350:391:treatment,417:449:cancer,458:487:cancer
Patients must have histologically confirmed, metastatic or unresectable malignancy of the following types: (a) non-small cell lung cancer (NSCLC), (b) triple-negative breast cancer (TNBC; defined by estrogen receptor [ER] < 1%, progesterone receptor [PR] < 1% and HER2 1+ or less by immunohistochemistry [IHC]; if HER-2 expression is 2+, a negative fluorescence in situ hybridization [FISH] testing is required) (c) pancreatic adenocarcinoma (PDAC), or (d) small cell lung cancer (SCLC)
1
[ "Patients", "must", "have", "histologically", "confirmed", ",", "metastatic", "or", "unresectable", "malignancy", "of", "the", "following", "types", ":", "(", "a", ")", "non-small", "cell", "lung", "cancer", "(", "NSCLC", ")", ",", "(", "b", ")", "triple-negative", "breast", "cancer", "(", "TNBC", ";", "defined", "by", "estrogen", "receptor", "[", "ER", "]", "<", "1", "%", ",", "progesterone", "receptor", "[", "PR", "]", "<", "1", "%", "and", "HER2", "1+", "or", "less", "by", "immunohistochemistry", "[", "IHC", "]", ";", "if", "HER-2", "expression", "is", "2+", ",", "a", "negative", "fluorescence", "in", "situ", "hybridization", "[", "FISH", "]", "testing", "is", "required", ")", "(", "c", ")", "pancreatic", "adenocarcinoma", "(", "PDAC", ")", ",", "or", "(", "d", ")", "small", "cell", "lung", "cancer", "(", "SCLC", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02525029
16:45:cancer
Diagnosis of a hormone responsive malignancy
1
[ "Diagnosis", "of", "a", "hormone", "responsive", "malignancy" ]
[ 0, 0, 0, 3, 3, 3 ]
NCT02302976
35:49:chronic_disease,54:74:chronic_disease,79:106:chronic_disease,135:157:chronic_disease,160:166:chronic_disease,180:219:chronic_disease,221:238:chronic_disease,251:279:treatment,281:301:chronic_disease,310:336:chronic_disease,338:344:chronic_disease,353:361:chronic_disease
a history of significant medical (cardiovascular) or neurological illness, ie prior myocardial infarction, current active symptoms of cardiovascular disease / angina, evidence of cocaine-related cardiovascular symptoms, prior arrhythmias or need for cardiovascular resuscitation, neurovascular events such as transient ischemic attacks, stroke, and/or seizures Parameters re: elevations in vital signs are now explicitly specified under Safety features built into our one-day self-administration paradigm)
1
[ "a", "history", "of", "significant", "medical", "(", "cardiovascular", ")", "or", "neurological", "illness", ",", "ie", "prior", "myocardial", "infarction", ",", "current", "active", "symptoms", "of", "cardiovascular", "disease", "/", "angina", ",", "evidence", "of", "cocaine-related", "cardiovascular", "symptoms", ",", "prior", "arrhythmias", "or", "need", "for", "cardiovascular", "resuscitation", ",", "neurovascular", "events", "such", "as", "transient", "ischemic", "attacks", ",", "stroke", ",", "and/or", "seizures", "Parameters", "re", ":", "elevations", "in", "vital", "signs", "are", "now", "explicitly", "specified", "under", "Safety", "features", "built", "into", "our", "one-day", "self-administration", "paradigm", ")" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 0, 2, 2, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 2, 2, 2, 0, 2, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02369653
1:14:treatment,26:73:treatment,78:100:treatment,105:120:treatment,
Major surgery [excluding Central Venous Access Device (CVAD) replacement and bone marrow aspiration and non-open biopsy] within the last 7 days prior to enrollment that may be associated with a risk of bleeding
1
[ "Major", "surgery", "[", "excluding", "Central", "Venous", "Access", "Device", "(", "CVAD", ")", "replacement", "and", "bone", "marrow", "aspiration", "and", "non-open", "biopsy", "]", "within", "the", "last", "7", "days", "prior", "to", "enrollment", "that", "may", "be", "associated", "with", "a", "risk", "of", "bleeding" ]
[ 1, 1, 0, 0, 1, 1, 1, 1, 1, 1, 0, 0, 0, 1, 1, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02667418
36:65:treatment,
Anticipation of need for long term systemic antibiotic treatment (beyond 7 days)
1
[ "Anticipation", "of", "need", "for", "long", "term", "systemic", "antibiotic", "treatment", "(", "beyond", "7", "days", ")" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0 ]
NCT01333046
,54:64:treatment,68:81:treatment,86:102:treatment
Patients greater than or equal to 18 years old after autologous or syngeneic SCT (as adjuvant therapy)
1
[ "Patients", "greater", "than", "or", "equal", "to", "18", "years", "old", "after", "autologous", "or", "syngeneic", "SCT", "(", "as", "adjuvant", "therapy", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 1, 1, 0 ]
NCT03042689
14:35:chronic_disease,78:94:chronic_disease,108:132:chronic_disease,134:159:chronic_disease,161:185:chronic_disease,200:218:chronic_disease,223:260:chronic_disease
Uncontrolled inter-current illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, uncontrolled hypertension, unstable angina pectoris, uncontrolled cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
1
[ "Uncontrolled", "inter-current", "illness", "including", ",", "but", "not", "limited", "to", ",", "ongoing", "or", "active", "infection", ",", "symptomatic", "congestive", "heart", "failure", ",", "uncontrolled", "hypertension", ",", "unstable", "angina", "pectoris", ",", "uncontrolled", "cardiac", "arrhythmia", ",", "or", "psychiatric", "illness/social", "situations", "that", "would", "limit", "compliance", "with", "study", "requirements" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 2, 2, 2, 0, 2, 2, 0, 2, 2, 2, 0, 0, 2, 2, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02098252
53:72:treatment
Hemorrhagic presentation with mass effect requiring surgical management
1
[ "Hemorrhagic", "presentation", "with", "mass", "effect", "requiring", "surgical", "management" ]
[ 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT00065676
1:25:chronic_disease
congestive heart failure
1
[ "congestive", "heart", "failure" ]
[ 2, 2, 2 ]
NCT02819635
1:19:treatment
immunosuppressants
1
[ "immunosuppressants" ]
[ 1 ]
NCT00432094
23:46:chronic_disease
Patients with serious uncontrolled infections
1
[ "Patients", "with", "serious", "uncontrolled", "infections" ]
[ 0, 0, 0, 2, 2 ]
NCT02012296
21:33:treatment,
Record of subject's enzalutamide start date and baseline PSA (within 28 days of starting) before starting enzalutamide available
1
[ "Record", "of", "subject", "'s", "enzalutamide", "start", "date", "and", "baseline", "PSA", "(", "within", "28", "days", "of", "starting", ")", "before", "starting", "enzalutamide", "available" ]
[ 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02520791
24:57:cancer,61:102:cancer,,138:153:treatment
Confirmed diagnosis of peripheral T-cell lymphoma (PTCL) or angioimmunoblastic T-cell lymphoma (AITL) that is refractory to at least one line of therapy
1
[ "Confirmed", "diagnosis", "of", "peripheral", "T-cell", "lymphoma", "(", "PTCL", ")", "or", "angioimmunoblastic", "T-cell", "lymphoma", "(", "AITL", ")", "that", "is", "refractory", "to", "at", "least", "one", "line", "of", "therapy" ]
[ 0, 0, 0, 3, 3, 3, 3, 0, 0, 0, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT02365766
1:26:cancer
Clinical stage cT2-4aN0M0
1
[ "Clinical", "stage", "cT2-4aN0M0" ]
[ 3, 3, 3 ]
NCT02982759
63:71:chronic_disease
Exclusion criteria include children with clinically-diagnosed dementia
1
[ "Exclusion", "criteria", "include", "children", "with", "clinically-diagnosed", "dementia" ]
[ 0, 0, 0, 0, 0, 0, 2 ]
NCT02842658
49:62:cancer
Subjects will have been recently diagnosed with breast cancer
1
[ "Subjects", "will", "have", "been", "recently", "diagnosed", "with", "breast", "cancer" ]
[ 0, 0, 0, 0, 0, 0, 0, 3, 3 ]
NCT02505035
1:45:chronic_disease,
Chronic obstructive pulmonary disease (COPD) with home oxygen dependence or 2 or more hospitalizations in the past 12 months
1
[ "Chronic", "obstructive", "pulmonary", "disease", "(", "COPD", ")", "with", "home", "oxygen", "dependence", "or", "2", "or", "more", "hospitalizations", "in", "the", "past", "12", "months" ]
[ 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02191098
39:50:chronic_disease
History or evidence of uncontrollable CNS disease
1
[ "History", "or", "evidence", "of", "uncontrollable", "CNS", "disease" ]
[ 0, 0, 0, 0, 0, 2, 2 ]
NCT01140087
1:4:chronic_disease
HIV positive
1
[ "HIV", "positive" ]
[ 2, 0 ]
NCT02389465
1:4:allergy_name,30:55:allergy_name,57:66:allergy_name
MRI contraindications (e.g., foreign metallic implants, pacemaker)
1
[ "MRI", "contraindications", "(", "e.g.", ",", "foreign", "metallic", "implants", ",", "pacemaker", ")" ]
[ 4, 0, 0, 0, 0, 4, 4, 4, 0, 4, 0 ]
NCT02165007
7:28:treatment
First allogeneic transplant
1
[ "First", "allogeneic", "transplant" ]
[ 0, 1, 1 ]
NCT02232516
1:18:chronic_disease,62:80:cancer,112:116:cancer
topical treatment may have been given for prior existence of cutaneous lymphoma that has since become systemic PTCL
1
[ "topical", "treatment", "may", "have", "been", "given", "for", "prior", "existence", "of", "cutaneous", "lymphoma", "that", "has", "since", "become", "systemic", "PTCL" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 3 ]
NCT03067571
61:79:chronic_disease
has any concurrent medical condition or disease (eg, active systemic infection, laboratory abnormalities) that is likely to interfere with study procedures or results, or that in the opinion of the investigator would constitute a hazard for participating in this study
1
[ "has", "any", "concurrent", "medical", "condition", "or", "disease", "(", "eg", ",", "active", "systemic", "infection", ",", "laboratory", "abnormalities", ")", "that", "is", "likely", "to", "interfere", "with", "study", "procedures", "or", "results", ",", "or", "that", "in", "the", "opinion", "of", "the", "investigator", "would", "constitute", "a", "hazard", "for", "participating", "in", "this", "study" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03059888
24:36:chronic_disease
Subject is at risk for tuberculosis
1
[ "Subject", "is", "at", "risk", "for", "tuberculosis" ]
[ 0, 0, 0, 0, 0, 2 ]
NCT02524379
22:30:treatment,
Known treatment with Bosentan within past 7 days
1
[ "Known", "treatment", "with", "Bosentan", "within", "past", "7", "days" ]
[ 0, 0, 0, 1, 0, 0, 0, 0 ]
NCT03179605
15:24:chronic_disease,,
Subjects with psoriasis involving ≥10% Body Surface Area (BSA), not including the face, scalp, groin, axillae and other intertriginous areas at the Baseline Visit
1
[ "Subjects", "with", "psoriasis", "involving", "≥10", "%", "Body", "Surface", "Area", "(", "BSA", ")", ",", "not", "including", "the", "face", ",", "scalp", ",", "groin", ",", "axillae", "and", "other", "intertriginous", "areas", "at", "the", "Baseline", "Visit" ]
[ 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01730118
27:36:treatment,40:60:treatment,91:104:cancer
Stable, concurrent use of tamoxifen or aromatase inhibitors for hormone receptor positive breast cancer are allowed
1
[ "Stable", ",", "concurrent", "use", "of", "tamoxifen", "or", "aromatase", "inhibitors", "for", "hormone", "receptor", "positive", "breast", "cancer", "are", "allowed" ]
[ 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 3, 3, 0, 0 ]
NCT01983475
,16:28:chronic_disease
Men with known hypogonadism prior to SCI
1
[ "Men", "with", "known", "hypogonadism", "prior", "to", "SCI" ]
[ 0, 0, 0, 2, 0, 0, 0 ]
NCT02429830
13:22:chronic_disease,,
Symptoms of dysphagia more than once per week within the last 3 months
1
[ "Symptoms", "of", "dysphagia", "more", "than", "once", "per", "week", "within", "the", "last", "3", "months" ]
[ 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02323191
,,60:69:treatment,,
Negative serum pregnancy test within 7 days prior to study treatment in premenopausal women and women less than or equal to (<=) 12 months post-menopause
1
[ "Negative", "serum", "pregnancy", "test", "within", "7", "days", "prior", "to", "study", "treatment", "in", "premenopausal", "women", "and", "women", "less", "than", "or", "equal", "to", "(", "<", "=", ")", "12", "months", "post-menopause" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03021902
1:54:chronic_disease
Pre-existing cognitive impairment or language barrier that prohibits outcomes assessment
1
[ "Pre-existing", "cognitive", "impairment", "or", "language", "barrier", "that", "prohibits", "outcomes", "assessment" ]
[ 2, 2, 2, 2, 2, 2, 0, 0, 0, 0 ]
NCT02057133
13:35:treatment,73:105:treatment,,124:156:treatment,158:169:treatment,171:180:treatment,186:204:cancer,234:257:treatment
For Part D (LY2835219 + exemestane): The participant must have received prior systemic endocrine therapy with at least one nonsteroidal aromatase inhibitor (anastrozole, letrozole) for metastatic disease and may be receiving ongoing therapy with exemestane
1
[ "For", "Part", "D", "(", "LY2835219", "+", "exemestane", ")", ":", "The", "participant", "must", "have", "received", "prior", "systemic", "endocrine", "therapy", "with", "at", "least", "one", "nonsteroidal", "aromatase", "inhibitor", "(", "anastrozole", ",", "letrozole", ")", "for", "metastatic", "disease", "and", "may", "be", "receiving", "ongoing", "therapy", "with", "exemestane" ]
[ 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 0, 0, 1, 1, 1, 0, 1, 0, 1, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01996449
21:34:allergy_name
Hypersensitivity to nitroprusside
1
[ "Hypersensitivity", "to", "nitroprusside" ]
[ 0, 0, 4 ]
NCT02473250
1:15:treatment,17:26:treatment,28:44:treatment,46:74:treatment,78:86:treatment
Metal implants, pacemaker, metal prostheses, metal orthodontic appliances or shrapnel in the body
1
[ "Metal", "implants", ",", "pacemaker", ",", "metal", "prostheses", ",", "metal", "orthodontic", "appliances", "or", "shrapnel", "in", "the", "body" ]
[ 1, 1, 0, 1, 0, 1, 1, 1, 0, 0, 0, 0, 1, 0, 0, 0 ]
NCT03008408
88:100:treatment,,
Patients in whom ovaries are present and were not previously menopausal at the time of hysterectomy, should have a serum estradiol <10 pm/mL to confirm ovarian senescence
1
[ "Patients", "in", "whom", "ovaries", "are", "present", "and", "were", "not", "previously", "menopausal", "at", "the", "time", "of", "hysterectomy", ",", "should", "have", "a", "serum", "estradiol", "<", "10", "pm/mL", "to", "confirm", "ovarian", "senescence" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02495168
21:30:treatment
on the first day of treatment (prior to randomization at Visit 2)
1
[ "on", "the", "first", "day", "of", "treatment", "(", "prior", "to", "randomization", "at", "Visit", "2", ")" ]
[ 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02250664
36:51:chronic_disease,101:110:treatment,114:127:treatment,
Be in good physical health without serious illness or change in health or medication (not including methadone or buprenorphine dose) in the past three months as determined by the license medical professional at each site
1
[ "Be", "in", "good", "physical", "health", "without", "serious", "illness", "or", "change", "in", "health", "or", "medication", "(", "not", "including", "methadone", "or", "buprenorphine", "dose", ")", "in", "the", "past", "three", "months", "as", "determined", "by", "the", "license", "medical", "professional", "at", "each", "site" ]
[ 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02562716
,,,151:163:treatment
women/men of reproductive potential must have agreed to use an effective contraceptive method for up to 3 months after the final administered dose of chemotherapy
1
[ "women/men", "of", "reproductive", "potential", "must", "have", "agreed", "to", "use", "an", "effective", "contraceptive", "method", "for", "up", "to", "3", "months", "after", "the", "final", "administered", "dose", "of", "chemotherapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02152995
11:20:treatment,,
All prior treatment-related toxicities must be Common Terminology Criteria for Adverse Events version 4.0 (CTCAE v 4.0) grade =< 1
1
[ "All", "prior", "treatment-related", "toxicities", "must", "be", "Common", "Terminology", "Criteria", "for", "Adverse", "Events", "version", "4.0", "(", "CTCAE", "v", "4.0", ")", "grade", "=", "<", "1" ]
[ 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01940757
12:34:chronic_disease
History of iron deficiency anemia
1
[ "History", "of", "iron", "deficiency", "anemia" ]
[ 0, 0, 2, 2, 2 ]
NCT02437370
40:53:allergy_name
Has known hypersensitivity to MK-3475 (pembrolizumab) or any of its incipients
1
[ "Has", "known", "hypersensitivity", "to", "MK-3475", "(", "pembrolizumab", ")", "or", "any", "of", "its", "incipients" ]
[ 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0 ]
NCT02193373
19:26:chronic_disease
Current or recent illness
1
[ "Current", "or", "recent", "illness" ]
[ 0, 0, 0, 2 ]
NCT01464034
,52:64:treatment,
Male pts cannot donate semen or sperm while taking pomalidomide and for 28 days after completing the study
1
[ "Male", "pts", "can", "not", "donate", "semen", "or", "sperm", "while", "taking", "pomalidomide", "and", "for", "28", "days", "after", "completing", "the", "study" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02784535
21:32:allergy_name
Hypersensitivity to atomoxetine
1
[ "Hypersensitivity", "to", "atomoxetine" ]
[ 0, 0, 4 ]
NCT02991677
,15:35:treatment
History of >1 chemotherapy regimen
1
[ "History", "of", ">", "1", "chemotherapy", "regimen" ]
[ 0, 0, 0, 0, 1, 1 ]
NCT02064036
10:28:treatment,30:52:treatment,57:78:treatment
Previous pelvic irradiation, prostate brachytherapy, or bilateral orchiectomy
1
[ "Previous", "pelvic", "irradiation", ",", "prostate", "brachytherapy", ",", "or", "bilateral", "orchiectomy" ]
[ 0, 1, 1, 0, 1, 1, 0, 0, 1, 1 ]
NCT02128906
48:64:chronic_disease,66:87:chronic_disease,89:114:chronic_disease
No uncontrolled intercurrent illness including active infection, uncontrolled diabetes, uncontrolled hypertension
1
[ "No", "uncontrolled", "intercurrent", "illness", "including", "active", "infection", ",", "uncontrolled", "diabetes", ",", "uncontrolled", "hypertension" ]
[ 0, 2, 2, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02102113
29:38:chronic_disease
Having a family member with psychosis
1
[ "Having", "a", "family", "member", "with", "psychosis" ]
[ 0, 0, 0, 0, 0, 2 ]
NCT02332369
14:30:chronic_disease
Preoperative ocular infection
1
[ "Preoperative", "ocular", "infection" ]
[ 0, 2, 2 ]
NCT02582827
34:42:chronic_disease,51:69:treatment,71:78:treatment,83:95:treatment,
All adverse events (AEs) (except alopecia) of any prior chemotherapy, surgery, or radiotherapy must have resolved to Grade ≤ 1
1
[ "All", "adverse", "events", "(", "AEs", ")", "(", "except", "alopecia", ")", "of", "any", "prior", "chemotherapy", ",", "surgery", ",", "or", "radiotherapy", "must", "have", "resolved", "to", "Grade", "≤", "1" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 1, 1, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02760498
28:50:treatment
Patients with a history of solid organ transplant
1
[ "Patients", "with", "a", "history", "of", "solid", "organ", "transplant" ]
[ 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT02519322
,,,,184:207:treatment
WOCBP must have a negative serum or urine pregnancy test (minimum sensitivity 25 IU/L or equivalent units of human chorionic gonadotropin [HCG]) within 24 hours prior to the start of investigational product
1
[ "WOCBP", "must", "have", "a", "negative", "serum", "or", "urine", "pregnancy", "test", "(", "minimum", "sensitivity", "25", "IU/L", "or", "equivalent", "units", "of", "human", "chorionic", "gonadotropin", "[", "HCG", "]", ")", "within", "24", "hours", "prior", "to", "the", "start", "of", "investigational", "product" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02710396
,25:35:chronic_disease
Subjects with ≤ Grade 2 neuropathy are an exception to this criterion and may qualify for the study
1
[ "Subjects", "with", "≤", "Grade", "2", "neuropathy", "are", "an", "exception", "to", "this", "criterion", "and", "may", "qualify", "for", "the", "study" ]
[ 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02924194
8:32:treatment
Use of cholinesterase inhibitor
1
[ "Use", "of", "cholinesterase", "inhibitor" ]
[ 0, 0, 1, 1 ]
NCT02564744
79:97:treatment
For Part 2 and Part 3 of the study, participants that are eligible to undergo first time HD-ASCT
1
[ "For", "Part", "2", "and", "Part", "3", "of", "the", "study", ",", "participants", "that", "are", "eligible", "to", "undergo", "first", "time", "HD-ASCT" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT01415752
,,,45:58:chronic_disease,60:79:chronic_disease,101:124:chronic_disease,129:149:treatment,168:176:chronic_disease
Patients must not have NYHA Class III or IV heart failure, uncontrolled angina, severe uncontrolled ventricular arrhythmias, or electrocardiographic evidence of acute ischemia
1
[ "Patients", "must", "not", "have", "NYHA", "Class", "III", "or", "IV", "heart", "failure", ",", "uncontrolled", "angina", ",", "severe", "uncontrolled", "ventricular", "arrhythmias", ",", "or", "electrocardiographic", "evidence", "of", "acute", "ischemia" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 2, 2, 0, 0, 0, 2, 2, 0, 0, 1, 0, 0, 0, 2 ]
NCT00902720
21:49:treatment
patients undergoing elective removal of an ovary for fertility preservation only
1
[ "patients", "undergoing", "elective", "removal", "of", "an", "ovary", "for", "fertility", "preservation", "only" ]
[ 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 0 ]
NCT02397889
,,100:120:treatment
Women of childbearing potential must have a negative pregnancy test at screening and prior to each intravenous infusion
1
[ "Women", "of", "childbearing", "potential", "must", "have", "a", "negative", "pregnancy", "test", "at", "screening", "and", "prior", "to", "each", "intravenous", "infusion" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT03104725
10:43:treatment
Taking a monoamine oxidase (MAO) inhibitor
1
[ "Taking", "a", "monoamine", "oxidase", "(", "MAO", ")", "inhibitor" ]
[ 0, 0, 1, 1, 1, 1, 0, 0 ]
NCT03092635
1:19:treatment,
Prior chemotherapy is allowed, but last dose must have been at least 2 months prior to enrollment
1
[ "Prior", "chemotherapy", "is", "allowed", ",", "but", "last", "dose", "must", "have", "been", "at", "least", "2", "months", "prior", "to", "enrollment" ]
[ 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02740543
1:19:chronic_disease,28:60:chronic_disease,64:89:chronic_disease
Pulmonary diseases such as Chronic Pulmonary Disease (COPD) or Interstitial Lung Disease
1
[ "Pulmonary", "diseases", "such", "as", "Chronic", "Pulmonary", "Disease", "(", "COPD", ")", "or", "Interstitial", "Lung", "Disease" ]
[ 2, 2, 0, 0, 2, 2, 2, 2, 0, 0, 0, 2, 2, 2 ]
NCT02169739
1:33:treatment,,112:120:chronic_disease
Diffusion-weighted imaging (DWI) lesion < 2.0cm in size at largest dimension and corresponding to the clinical syndrome
1
[ "Diffusion-weighted", "imaging", "(", "DWI", ")", "lesion", "<", "2.0cm", "in", "size", "at", "largest", "dimension", "and", "corresponding", "to", "the", "clinical", "syndrome" ]
[ 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2 ]
NCT00492778
23:35:treatment
Patients who received chemotherapy directed at the present recurrence
1
[ "Patients", "who", "received", "chemotherapy", "directed", "at", "the", "present", "recurrence" ]
[ 0, 0, 0, 1, 0, 0, 0, 0, 0 ]
NCT02669173
23:37:treatment
Patients on full-dose anticoagulants
1
[ "Patients", "on", "full-dose", "anticoagulants" ]
[ 0, 0, 0, 1 ]
NCT02272998
28:55:treatment
Patients who have received prior FGFR targeted therapy
1
[ "Patients", "who", "have", "received", "prior", "FGFR", "targeted", "therapy" ]
[ 0, 0, 0, 0, 1, 1, 1, 1 ]
NCT00338377
15:18:treatment,31:34:cancer,64:86:cancer
Patients with MRI evidence of LMD, with or without evidence of malignant cells in CSF (positive cytology)
1
[ "Patients", "with", "MRI", "evidence", "of", "LMD", ",", "with", "or", "without", "evidence", "of", "malignant", "cells", "in", "CSF", "(", "positive", "cytology", ")" ]
[ 0, 0, 1, 0, 0, 3, 0, 0, 0, 0, 0, 0, 3, 3, 3, 3, 0, 0, 0, 0 ]
NCT03158974
1:24:treatment,
Topical corticosteroids if greater than 2 gm/day
1
[ "Topical", "corticosteroids", "if", "greater", "than", "2", "gm/day" ]
[ 1, 1, 0, 0, 0, 0, 0 ]
NCT02573883
8:11:chronic_disease
Active UTI
1
[ "Active", "UTI" ]
[ 0, 2 ]